help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-1328
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Supplemental Data
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, C. A.
Right arrow Articles by Magré, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, C. A.
Right arrow Articles by Magré, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 93, No. 4 1129-1134
Copyright © 2008 by The Endocrine Society


CLINICAL CASE SEMINAR

Association of a Homozygous Nonsense Caveolin-1 Mutation with Berardinelli-Seip Congenital Lipodystrophy

C. A. Kim, Marc Delépine1, Emilie Boutet1, Haquima El Mourabit, Soazig Le Lay, Muriel Meier, Mona Nemani, Etienne Bridel, Claudia C. Leite, Debora R. Bertola, Robert K. Semple, Stephen O’Rahilly, Isabelle Dugail, Jacqueline Capeau, Mark Lathrop and Jocelyne Magré

Department of Pediatrics (C.A.K., D.R.B.), Instituto da Criança, University of Sao Paulo, 05403-900 Sao Paulo, Brazil; Commissariat à l’Energie Atomique (M.D., M.L.), Institut de Génomique, Centre National de Génotypage, 91057 Evry, France; Unité Mixte de Recherche (UMR)_S893 (E.Bo., H.E.M., M.M., M.N., J.C., J.M.), Institut National de la Santé et de la Recherche Médicale (INSERM), Université Pierre et Marie Curie (UPMC) Univ Paris 06, Centre de Recherche (CDR) Saint-Antoine, F-75012 Paris, France; UMR_S872 (S.L.L., I.D.), INSERM, UPMC Univ Paris 06, CDR des Cordeliers, F-75006 Paris, France; Service d’Imagerie Médicale (E.Br.), Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Radiology (C.C.L.), School of Medicine, University of Sao Paulo, 05403-001 Sao Paulo, Brazil; and Department of Clinical Biochemistry (R.K.S., S.O.), University of Cambridge, Addenbrooke’s Hospital, Cambridge CB2 2QR, United Kingdom

Address all correspondence and requests for reprints to: Jocelyne Magré, INSERM UMR_S893, Faculté de Médecine Pierre et Marie Curie, Site Saint-Antoine, 27 rue Chaligny, 75012 Paris, France. E-mail: Jocelyne.Magre{at}st-antoine.inserm.fr.

Context: Berardinelli-Seip congenital lipodystrophy (BSCL) is a rare recessive disease characterized by near absence of adipose tissue, resulting in severe dyslipidemia and insulin resistance. In most reported cases, BSCL is due to alterations in either seipin, of unknown function, or 1-acylglycerol-3-phosphate acyltransferase-β (AGPAT2), which catalyzes the formation of phosphatidic acid.

Objective: We sought to determine the genetic origin of the unexplained cases of BSCL. We thus sequenced CAV1, encoding caveolin-1, as a candidate gene involved in insulin signaling and lipid homeostasis. CAV1 is a key structural component of plasma membrane caveolae, and Cav1-deficient mice display progressive loss of adipose tissue and insulin resistance.

Design: We undertook phenotyping studies and molecular screening of CAV1 in four patients with BSCL with no mutation in the genes encoding either seipin or AGPAT2.

Results: A homozygous nonsense mutation (p.Glu38X) was identified in CAV1 in a patient with BSCL born from a consanguineous union. This mutation affects both the {alpha}- and β-CAV1 isoforms and ablates CAV1 expression in skin fibroblasts. Detailed magnetic resonance imaging of the proband confirmed near total absence of both sc and visceral adipose tissue, with only vestigial amounts in the dorsal sc regions. In keeping with the lack of adipose tissue, the proband was also severely insulin resistant and dyslipidemic. In addition, the proband had mild hypocalcemia likely due to vitamin D resistance.

Conclusions: These findings identify CAV1 as a new BSCL-related gene and support a critical role for caveolins in human adipocyte function.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. Garg and A. K. Agarwal
Caveolin-1: A New Locus for Human Lipodystrophy
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1183 - 1185.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society